0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA Oncology | 
Invited Commentary |  ONLINE FIRST
Rick Chappell, PhD; Xiaotian Zhu, PhD
JAMA Oncol. Published online April 28, 2016. doi:10.1001/jamaoncol.2016.0001

JAMA Internal Medicine | 
Original Investigation |  ONLINE FIRST
Victoria L. Tang, MD, MAS; Ying Shi, PhD; Kathy Fung, MS; et al.
JAMA Intern Med. Published online April 04, 2016. doi:10.1001/jamainternmed.2016.0695
Includes: Supplemental Content

JAMA Oncology | 
Research Letter | 
Firas Abdollah, MD; Maxine Sun, MPH; Jesse D. Sammon, DO; et al.
JAMA Oncol. 2016;2(4):543-545. doi:10.1001/jamaoncol.2015.5871.

JAMA Oncology | 
Original Investigation | 
Nicholas D. James, PhD, FRCR, FRCP; Sarah J. Pirrie, MSc; Ann M. Pope, PhD; et al.
JAMA Oncol. 2016;2(4):493-499. doi:10.1001/jamaoncol.2015.5570.
Includes: Supplemental Content

JAMA Internal Medicine | 
Research Letter | 
Michael E. Zavaski, MD; Christian P. Meyer, MD; Jesse D. Sammon, DO; et al.
JAMA Intern Med. 2016;176(4):546-547. doi:10.1001/jamainternmed.2015.7901.

JAMA Oncology | 
Editorial | 
Michael Kolinsky, BSc, MD; Pasquale Rescigno, MD; Johann S. de Bono, MB, ChB, MSc, FRCP, PhD, FMedSci
JAMA Oncol. 2016;2(4):437-438. doi:10.1001/jamaoncol.2015.4918.

JAMA Oncology | 
Invited Commentary | 
Saroj Niraula, MBBS, MD, MSc; Ian F. Tannock, MD, PhD
JAMA Oncol. 2016;2(4):461-462. doi:10.1001/jamaoncol.2015.4682.

JAMA Oncology | 
Original Investigation | 
Dawn L. Hershman, MD, MS; Joseph M. Unger, PhD; Jason D. Wright, MD; et al.
JAMA Oncol. 2016;2(4):453-461. doi:10.1001/jamaoncol.2015.4655.
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation | 
Maxine Sun, MPH; Toni K. Choueiri, MD; Ole-Petter R. Hamnvik, MD; et al.
JAMA Oncol. 2016;2(4):500-507. doi:10.1001/jamaoncol.2015.4917.

JAMA Oncology | 
Invited Commentary | 
Sean E. McGuire, MD, PhD
JAMA Oncol. 2016;2(4):480-481. doi:10.1001/jamaoncol.2015.4952.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Invited Commentary  | 
Describing Differences in Survival Curves
Rick Chappell, PhD; Xiaotian Zhu, PhD
JAMA Internal Medicine
Original Investigation  | 
Clinician Factors Associated With Prostate-Specific Antigen Screening in Older Veterans With Limited Life Expectancy
Victoria L. Tang, MD, MAS; Ying Shi, PhD; Kathy Fung, MS; et al.
JAMA Internal Medicine
Research Letter  | 
Differences in Prostate-Specific Antigen Testing Among Urologists and Primary Care Physicians Following the 2012 USPSTF Recommendations
Michael E. Zavaski, MD; Christian P. Meyer, MD; Jesse D. Sammon, DO; et al.
JAMA Oncology
Editorial  | 
Chemical or Surgical Castration—Is This Still an Important Question?
Michael Kolinsky, BSc, MD; Pasquale Rescigno, MD; Johann S. de Bono, MB, ChB, MSc, FRCP, PhD, FMedSci